Literature DB >> 7908440

A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated.

G Pei1, P Samama, M Lohse, M Wang, J Codina, R J Lefkowitz.   

Abstract

The beta 2-adrenergic receptor (beta 2AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant beta 2AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (Gs)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant beta AR-specific kinase (beta ARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates Gs protein and is identical to the beta ARK substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908440      PMCID: PMC43437          DOI: 10.1073/pnas.91.7.2699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.

Authors:  J A Pitcher; J Inglese; J B Higgins; J L Arriza; P J Casey; C Kim; J L Benovic; M M Kwatra; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

Review 2.  Model systems for the study of seven-transmembrane-segment receptors.

Authors:  H G Dohlman; J Thorner; M G Caron; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  On the application of "a plausible model" of allosteric proteins to the receptor for acetylcholine.

Authors:  A Karlin
Journal:  J Theor Biol       Date:  1967-08       Impact factor: 2.691

4.  Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function.

Authors:  S Cotecchia; S Exum; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor.

Authors:  B K Kobilka; R A Dixon; T Frielle; H G Dohlman; M A Bolanowski; I S Sigal; T L Yang-Feng; U Francke; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

6.  Constitutively active mutants of the alpha 2-adrenergic receptor.

Authors:  Q Ren; H Kurose; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

7.  Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands.

Authors:  J Codina; J D Hildebrandt; R D Sekura; M Birnbaumer; J Bryan; C R Manclark; R Iyengar; L Birnbaumer
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

8.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

9.  The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system.

Authors:  R A Cerione; J Codina; J L Benovic; R J Lefkowitz; L Birnbaumer; M G Caron
Journal:  Biochemistry       Date:  1984-09-25       Impact factor: 3.162

10.  The mammalian beta 2-adrenergic receptor: purification and characterization.

Authors:  J L Benovic; R G Shorr; M G Caron; R J Lefkowitz
Journal:  Biochemistry       Date:  1984-09-25       Impact factor: 3.162

View more
  26 in total

1.  Modulation of histamine H(2) receptor signalling by G-protein-coupled receptor kinase 2 and 3.

Authors:  M S Rodriguez-Pena; H Timmerman; R Leurs
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.

Authors:  D Ramsay; N Bevan; S Rees; G Milligan
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 3.  Dopamine receptors for every species: gene duplications and functional diversification in Craniates.

Authors:  Stéphane Le Crom; Marika Kapsimali; Pierre-Olivier Barôme; Philippe Vernier
Journal:  J Struct Funct Genomics       Date:  2003

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 5.  Review: amino acid domains involved in constitutive activation of G-protein-coupled receptors.

Authors:  P J Pauwels; T Wurch
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

6.  A constitutively active mutant of the alpha 1B-adrenergic receptor can cause greater agonist-dependent down-regulation of the G-proteins G9 alpha and G11 alpha than the wild-type receptor.

Authors:  T W Lee; A Wise; S Cotecchia; G Milligan
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

7.  Rapid desensitization of the TRH receptor and persistent desensitization of its constitutively active mutant.

Authors:  I Zaltsman; H Grimberg; M Lupu-Meiri; L Lifschitz; Y Oron
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

8.  The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.

Authors:  C Taylor Gilliland; Catherina L Salanga; Tetsuya Kawamura; JoAnn Trejo; Tracy M Handel
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

9.  Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.

Authors:  Marie Humbert-Claude; Elisabeth Davenas; Florence Gbahou; Ludwig Vincent; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2011-09-13       Impact factor: 4.530

10.  Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Authors:  Laura C Sullivan; Teresa S Chavera; Raehannah J Jamshidi; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.